%0 Journal Article
%A Fragiel, Marcos
%A Miro, Oscar
%A Llorens, Pere
%A Jimenez, Sonia
%A Piñera, Pascual
%A Burillo, Guillermo
%A Martin, Alfonso
%A Martin-Sanchez, Francisco J
%A Garcia-Lamberechts, Eric J
%A Jacob, Javier
%A Alquezar-Arbe, Aitor
%A Juarez, Ricardo
%A Jimenez, Blas
%A Del Rio, Rigoberto
%A Mateo Roca, Miriam
%A Garcia, Arturo H
%A Lopez Laguna, Nieves
%A Lopez Diez, Maria P
%A Pedraza Garcia, Jorge
%A Fernandez de Simon Almela, Amparo
%A Lopez Diaz, Juan J
%A Eiroa Hernandez, Patricia
%A Ruiz de Lobera, Noemi
%A Porta-Etessam, Jesus
%A Fernandez Perez, Cristina
%A Calvo, Elpidio
%A Gonzalez Del Castillo, Juan
%T Incidence, clinical, risk factors and outcomes of Guillain-Barré in Covid-19.
%D 2020
%U http://hdl.handle.net/10668/16761
%X We diagnosed 11 Guillain-Barré syndrome (GBS) cases among 71,904 COVID patients attended at 61 Spanish emergency departments (EDs) during the 2-month pandemic peak. The relative frequency of GBS among ED patients was higher in COVID (0.15‰) than non-COVID (0.02‰) patients (odds ratio [OR] = 6.30, 95% confidence interval [CI] = 3.18-12.5), as was the standardized incidence (9.44 and 0.69 cases/100,000 inhabitant-years, respectively, OR = 13.5, 95% CI = 9.87-18.4). Regarding clinical characteristics, olfactory-gustatory disorders were more frequent in COVID-GBS than non-COVID-GBS (OR = 27.59, 95% CI = 1.296-587) and COVID-non-GBS (OR = 7.875, 95% CI = 1.587-39.09) patients. Although COVID-GBS patients were more frequently admitted to intensive care, mortality was not increased versus control groups. Our results suggest SARS-CoV-2 could be another viral infection causing GBS. ANN NEUROL 2021;89:598-603.
%K Adult
%K Aged
%K COVID-19
%K Case-Control Studies
%K Female
%K Guillain-Barre Syndrome
%K Hospital Mortality
%K Humans
%~